litlas
ログインアカウント作成

Kevin J. Harrington

1961–2025 年に発表

294
論文数
53,826
被引用数
112
h 指数
275
i10 指数

被引用数

Kevin J. Harrington の年別被引用数1962 年: 被引用 1 件1964 年: 被引用 1 件1973 年: 被引用 1 件1982 年: 被引用 1 件1987 年: 被引用 1 件1988 年: 被引用 1 件1989 年: 被引用 1 件1990 年: 被引用 3 件1992 年: 被引用 1 件1994 年: 被引用 2 件1995 年: 被引用 7 件1996 年: 被引用 6 件1997 年: 被引用 6 件1998 年: 被引用 8 件1999 年: 被引用 8 件2000 年: 被引用 13 件2001 年: 被引用 18 件2002 年: 被引用 18 件2003 年: 被引用 18 件2004 年: 被引用 44 件2005 年: 被引用 42 件2006 年: 被引用 38 件2007 年: 被引用 60 件2008 年: 被引用 116 件2009 年: 被引用 173 件2010 年: 被引用 168 件2011 年: 被引用 219 件2012 年: 被引用 264 件2013 年: 被引用 238 件2014 年: 被引用 263 件2015 年: 被引用 271 件2016 年: 被引用 354 件2017 年: 被引用 491 件2018 年: 被引用 617 件2019 年: 被引用 1,993 件2020 年: 被引用 2,804 件2021 年: 被引用 2,958 件2022 年: 被引用 2,627 件2023 年: 被引用 2,020 件2024 年: 被引用 2,873 件2025 年: 被引用 1,626 件2026 年: 被引用 50 件1963 年は被引用が無いため表示していません1965〜1972 年は被引用が無いため表示していません1974〜1981 年は被引用が無いため表示していません1983〜1986 年は被引用が無いため表示していません1991 年は被引用が無いため表示していません1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,116 件、この内訳の 23.3%中国: 引用元論文 3,511 件、この内訳の 16%イギリス: 引用元論文 1,506 件、この内訳の 6.9%ドイツ: 引用元論文 1,095 件、この内訳の 5%フランス: 引用元論文 939 件、この内訳の 4.3%イタリア: 引用元論文 921 件、この内訳の 4.2%カナダ: 引用元論文 818 件、この内訳の 3.7%日本: 引用元論文 715 件、この内訳の 3.2%オランダ: 引用元論文 674 件、この内訳の 3.1%オーストラリア: 引用元論文 550 件、この内訳の 2.5%スペイン: 引用元論文 538 件、この内訳の 2.4%スイス: 引用元論文 418 件、この内訳の 1.9%
0%23.3%その他 23.5%

機関

分野

  • Medicine53.8%
  • Biochemistry, Genetics and Molecular Biology26.4%
  • Immunology and Microbiology9.3%
  • Engineering4.1%
  • Materials Science2%
  • Physics and Astronomy1.8%
  • その他2.6%

トピック

  • Cancer Immunotherapy and Biomarkers9.1%
  • Immunotherapy and Immune Responses4.7%
  • Head and Neck Cancer Studies4.6%
  • CAR-T cell therapy research4.4%
  • Virus-based gene therapy research3.4%
  • Nanoplatforms for cancer theranostics2.3%
  • その他71.5%

共著者

全論文

検索で開く
  1. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

    著者: Barbara Burtness, Kevin J. Harrington, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro, Amanda Psyrri, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett Hughes, Ricard Mesı́a, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Ruey‐Long Hong, René González Mendoza, Ananya Roy, Yayan Zhang, Burak Gümüşçü, Jonathan D. Cheng, Fan Jin, Danny Rischin, Guillermo Lerzo, Marcelo Tatangelo, Mirta Varela, Juan José Zarbá, Michael Boyer, Hui Gan, Bo Gao, Brett Hughes, Girish Mallesara, Danny Rischin, Anne L. Taylor, Martin Burian, Thorsten Fuereder, Richard Greil, Carlos H. Barrios, Dalvaro Oliveira de Castro Junior, Gilberto de Castro, Fábio Franke, Gustavo Girotto, Iane Pinto Figueiredo Lima, Ulisses Ribaldo Nicolau, Gustavo Dix Junqueira Pinto, Lucas Vieira dos Santos, Ana-Paula Victorino, Neil Chua, Félix Couture, Richard Gregg, Aaron R. Hansen, John Hilton, Joy McCarthy, Denis Soulières, Rodrigo Ascuí, Pablo Gonzalez, Luis J. Villanueva-Rivera, Marco Torregroza, Ángela R. Zambrano, Petra Holečková, Zdeněk Král, Bohuslav Melichar, Prausova Jana, Milan Vošmik, Maria Andersen, Niels Gyldenkerne, Hannes Jürgens, Kadri Putnik, Petri Reinikainen, Viktor Gruenwald, Simon Laban, Gerasimos Aravantinos, Ioannis Boukovinas, Vassilis Georgoulias, Amanda Psyrri, D.L.W. Kwong, Yousuf Al-Farhat, Tibor Csőszi, József Erfán, Geza Horvai, László Landherr, Éva Remenár, Ágnes Ruzsa, Judit Szota, Salem Billan, Iris Gluck, Orit Gutfeld, Aron Popovtzer, Marco Benasso, Simona Bui, Vittorio Ferrari, Lisa Licitra, Franco Nolè, Takashi Fujii, Yasushi Fujimoto, Nobuhiro Hanai, Hiroki Hara, Koji Matsumoto, Kenji Mitsugi ほか 119 名 - The Lancet 2019 被引用: 3,211

  2. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

    著者: Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, J. Guigay, A. Dimitrios Colevas, Lisa Licitra, Kevin J. Harrington, Stefan Kasper, Everett E. Vokes, Caroline Even, Francis P. Worden, Nabil F. Saba, Lara Carmen Iglesias Docampo, Robert I. Haddad, Tamara Rordorf, Naomi Kiyota, Makoto Tahara, Manish Monga, Mark Lynch, William J. Geese, Justin Kopit, James W. Shaw, Maura L. Gillison - New England Journal of Medicine 2016 被引用: 5,078

  3. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence

    著者: Holly E. Barker, James Paget, Aadil Khan, Kevin J. Harrington - Nature reviews. Cancer 2015 被引用: 2,118

  4. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

    著者: Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio, Thomas Amatruda, Neil Senzer, Jason Chesney, Keith A. Delman, Lynn E. S̄pitler, Igor Puzanov, Sanjiv S. Agarwala, Mohammed Milhem, Lee D. Cranmer, Brendan D. Curti, Karl D. Lewis, Merrick I. Ross, Troy H. Guthrie, Gerald P. Linette, Gregory A. Daniels, Kevin J. Harrington, Mark R. Middleton, Wilson H. Miller, Jonathan S. Zager, Yining Ye, Bin Yao, Li Ai, Susan Doleman, Ari M. Vanderwalde, Jennifer Gansert, Robert S. Coffin - Journal of Clinical Oncology 2015 被引用: 2,598

  5. Inflammatory microenvironment remodelling by tumour cells after radiotherapy

    著者: Martin McLaughlin, Emmanuel C. Patin, Malin Pedersen, Anna Wilkins, Magnus T. Dillon, Alan Melcher, Kevin J. Harrington - Nature reviews. Cancer 2020 被引用: 901

  6. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

    著者: Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau, José Dinis, Lisa Licitra, Myung‐Ju Ahn, Ainara Soria, Jean‐Pascal Machiels, Nicolas Mach, Ranee Mehra, Barbara Burtness, Pingye Zhang, Jonathan D. Cheng, Ramona F. Swaby, Kevin J. Harrington, Mirelis Acosta-Rivera, Douglas R. Adkins, Morteza Aghmesheh, Myung‐Ju Ahn, Mario Airoldi, Eduardas Aleknavičius, Yousuf Al-Farhat, Alain P. Algazi, Salah Almokadem, Anna Alyasova, Jessica R. Bauman, Marco Benasso, Alfonso Berrocal, Victoria Bray, Barbara Burtness, Francesco Caponigro, Ana Castro, Terrence P. Cescon, Kelvin Chan, Arvind Chaudhry, Bruno Chauffert, Ezra E.W. Cohen, Tibor Csőszi, Jan Paul de Boer, Jean‐Pierre Delord, Andreas Dietz, José Dinis, Charlotte Dupuis, Laurence Digue, József Erfán, Yolanda Escobar Alvarez, Mererid Evans, Mary J. Fidler, Martin Förster, Signe Friesland, Apar Kishor Ganti, Lionnel Geoffrois, Clíona Grant, Viktor Gruenwald, Kevin J. Harrington, Thomas K. Hoffmann, Geza Horvai, Arturas Inčiūra, Raymond Woo-Jun Jang, Petra Jankowska, Antonio Jimeno, Mano Joseph, Alejandro Juárez Ramiro, Bogusława Karaszewska, Andrzej Kawecki, Ulrich Keilholz, Ulrich Keller, Sung‐Bae Kim, Judit Kocsis, Nuria Kotecki, Mark Kozloff, J. Lambea, László Landherr, Yuri Lantsukhay, Sergey Lazarev, Lip Way Lee, Christophe Le Tourneau, Lisa Licitra, Igor Lifirenko, Nicolas Mach, Danko Martincic, О. В. Маторин, Margaret McGrath, Jean‐Pascal Machiels, Ranee Mehra, Krzysztof Misiukiewicz, John C. Morris, Ф. Ф. Муфазалов, Jiaxin Niu, Devraj Srinivasan, Pedro Pérez Segura, Daniel Rauch, Maria Leonor Ribeiro, Cristina P. Rodriguez, Frédéric Rolland, Antonio Russo, Ágnes Ruzsa, Frederico Sanches, Sangwon Shin, Mikhail Shtiveland ほか 13 名 - The Lancet 2018 被引用: 1,697

  7. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    著者: Lorenzo Galluzzi, Ilio Vitale, Sarah H. Warren, Sandy Adjemian, Patrizia Agostinis, Aitziber Buqué Martinez, Timothy A. Chan, George Coukos, Sandra Demaria, Éric Deutsch, Dobrin Draganov, Richard L. Edelson, Silvia C. Formenti, Jitka Fučíková, Lucia Gabriele, Udo S. Gaipl, Sofia R. Gameiro, Abhishek D. Garg, Encouse B. Golden, Jian Han, Kevin J. Harrington, Akseli Hemminki, James W. Hodge, Dewan Md Sakib Hossain, Tim Illidge, Michael Karin, Howard L. Kaufman, Oliver Kepp, Guido Kroemer, Juan José Lasarte, Sherene Loi, Michael T. Lotze, Gwenola Manic, Taha Merghoub, Alan Melcher, Karen Mossman, Felipe Prósper, Øystein Rekdal, María Rescigno, Chiara Riganti, Antonella Sistigu, Mark J. Smyth, Radek Špíšek, John Stagg, Bryan E. Strauss, Daolin Tang, Kazuki Tatsuno, Stefaan Van Gool, Peter Vandenabeele, Takahiro Yamazaki, Dmitriy Zamarin, Laurence Zitvogel, Alessandra Cesano, Francesco M. Marincola - Journal for ImmunoTherapy of Cancer 2020 被引用: 1,061

  8. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts

    著者: Fernando Calvo, Nil Ege, A. Grande-García, Steven Hooper, Robert P. Jenkins, Shahid I Chaudhry, Kevin J. Harrington, Peter Williamson, Emad Moeendarbary, Guillaume Charras, Erik Sahai - Nature Cell Biology 2013 被引用: 1,422

  9. Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study

    著者: Kevin J. Harrington, Barbara Burtness, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro, Amanda Psyrri, Irene Braña, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett Hughes, Ricard Mesı́a, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Jianxin Lin, Burak Gümüşçü, Ramona F. Swaby, Danny Rischin - Journal of Clinical Oncology 2022 被引用: 490

  10. Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

    著者: Nancy Y. Lee, Robert L. Ferris, Amanda Psyrri, Robert I. Haddad, Makoto Tahara, Jean Bourhis, Kevin J. Harrington, Peter Mu‐Hsin Chang, Jin‐Ching Lin, Mohammad Razaq, Maria Margarida Teixeira, József Lövey, J. Chamois, Antonio Rueda, Chaosu Hu, Lara Dunn, Mikhail Dvorkin, Steven De Beukelaer, Dmitri Pavlov, Holger Thurm, Ezra E.W. Cohen - The Lancet Oncology 2021 被引用: 617

  11. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

    著者: Ezra E.W. Cohen, R. Bryan Bell, Carlo Bifulco, Barbara Burtness, Maura L. Gillison, Kevin J. Harrington, Quynh‐Thu Le, Nancy Y. Lee, Rom S. Leidner, Rebecca Lewis, Lisa Licitra, Hisham Mehanna, Loren K. Mell, Adam Raben, Andrew G. Sikora, Ravindra Uppaluri, Fernanda Whitworth, Dan P. Zandberg, Robert L. Ferris - Journal for ImmunoTherapy of Cancer 2019 被引用: 738

  12. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

    著者: Hisham Mehanna, Max Robinson, A. Hartley, Anthony Kong, Bernadette Foran, Tessa Fulton‐Lieuw, Matthew J. Dalby, Pankaj Mistry, Mehmet Şen, L. O’Toole, H. Al Booz, K. Dyker, R. Molerón, S. Whitaker, Sinéad Brennan, Audrey Cook, Matthew Griffin, E. Aynsley, Martin Rolles, Emma De Winton, Andrew K. Chan, Devraj Srinivasan, Ioanna Nixon, Joanne Grumett, C. René Leemans, Jan Buter, Julia Henderson, Kevin J. Harrington, Christopher C. McConkey, Alastair Gray, Janet Dunn, R. Molerón, Orla McArdle, K. Dyker, H. Al Booz, L. O’Toole, Audrey Cook, David Husband, Vivienne Loo, Win Soe, E. Aynsley, Sridhar Thiagarajan, Petra Jankowska, Mano Joseph, K. Geropantas, Deepali Vaidya, Matthew Griffin, A. Hartley, Rengarajan Vijayan, David Hwang, Kevin J. Harrington, Laura Pettit, S. Whitaker, Emma De Winton, Martin Rolles, Sinéad Brennan, Mehmet Şen, R. Mendes, Martin Förster, Andrew K. Chan, Mererid Evans, Jan Buter, Devraj Srinivasan, B. Foran, Paul Nankivell, Jennifer Bryant, Neil Sharma, Rachel Spruce, Jill Brooks, Nikos Batis, Tom Roques, Margaret Bidmead, Huiqi Yang, Christopher M. Nutting, Justine Tyler, Julia Henderson, Helen Baines, Anne Gasnier, Elizabeth Miles, Catharine H. Clark, Mererid Evans - The Lancet 2018 被引用: 1,034

  13. Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies

    著者: Frederick Arce Vargas, Andrew J.S. Furness, Kevin Litchfield, Kroopa Joshi, Rachel Rosenthal, Ehsan Ghorani, Isabelle Solomon, Marta H. Lesko, Nora Ruef, Claire Roddie, Jake Y. Henry, Lavinia Spain, Assma Ben Aïssa, Andrew Georgiou, Yien Ning Sophia Wong, Myles Smith, D. Strauß, Andrew Hayes, David Nicol, Tim O'Brien, Linda Mårtensson, Anne Ljungars, Ingrid Teige, Björn Frendéus, Kevin J. Harrington, Alan Melcher, Andrew Wotherspoon, Nicholas Francis, Ben Challacombe, Archana Fernando, Steve Hazell, Ashish Chandra, Lisa Pickering, Joanna Lynch, Sarah Rudman, Simon Chowdhury, Karen Harrison‐Phipps, Mary Varia, Catherine Horsfield, Alexander Polson, Gordon Stamp, Marie O’Donnell, William Drake, Peter Hill, David Hrouda, E J Mayer, Jonathan Olsburgh, G. Kooiman, Kevin C. O’Connor, Grant D. Stewart, Michael Aitchison, Maxine Tran, Nicos Fotiadis, Hema Verma, José I. López, J.F. Lester, Fiona J. E. Morgan, Malgorzata Kornaszewska, Richard Attanoos, Haydn Adams, Helen Davies, Dean A. Fennell, Jacqui Shaw, John Le Quesne, Apostolos Nakas, Sridhar Rathinam, William Monteiro, Hilary Marshall, Louise Nelson, Jonathan Bennett, Joan Riley, Lindsay Primrose, Luke Martinson, Girija Anand, Sajid Khan, M. Nicolson, Keith M. Kerr, Shirley Palmer, Hardy Remmen, J. Richard Miller, Keith Buchan, Mahendran Chetty, Lesley Gomersall, Sara Lock, Babu Naidu, Gerald Langman, Simon Trotter, Mary Bellamy, Hollie Bancroft, Amy Kerr, Salma Kadiri, Joanne Webb, Gary Middleton, Madava Djearaman, Yvonne Summers, Raffaele Califano, P. W. J. Taylor, Rajesh Shah, Piotr Krysiak, Kendadai Rammohan ほか 155 名 - Cancer Cell 2018 被引用: 585

  14. Optimizing oncolytic virotherapy in cancer treatment

    著者: Kevin J. Harrington, Daniel J. Freeman, Elizabeth J. Kelly, James A. Harper, Jean‐Charles Soria - Nature Reviews Drug Discovery 2019 被引用: 521

  15. Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice

    著者: Laura Evgin, Tim Kottke, Jason M. Tonne, Jill Thompson, Amanda L. Huff, Jacob P. van Vloten, Madelyn Moore, Josefine Michael, Christopher B. Driscoll, José S. Pulido, Eric Swanson, Richard B. Kennedy, Matt Coffey, Houra Loghmani, Luis Sánchez-Pérez, Gloria Olivier, Kevin J. Harrington, Hardev Pandha, Alan Melcher, Rosa María Díaz, Richard G. Vile - Science Translational Medicine 2022 被引用: 202

  16. Immunological impact of cell death signaling driven by radiation on the tumor microenvironment

    著者: María E. Rodríguez-Ruiz, Ilio Vitale, Kevin J. Harrington, Ignacio Melero, Lorenzo Galluzzi - Nature Immunology 2019 被引用: 376

  17. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells

    著者: Cédric Gaggioli, Steven Hooper, Cristina Hidalgo-Carcedo, Robert Grosse, John F. Marshall, Kevin J. Harrington, Erik Sahai - Nature Cell Biology 2007 被引用: 1,558

  18. Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas

    著者: Kevin J. Harrington, Joshua Brody, M. Ingham, James Strauss, Sašo Čemerski, M. Wang, Archie Tse, Anuradha Khilnani, Aurélien Marabelle, Talia Golan - Annals of Oncology 2018 被引用: 276

  19. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

    著者: Christopher M. Nutting, James P. Morden, Kevin J. Harrington, Teresa Guerrero Urbano, Shreerang Bhide, Catharine H. Clark, Elizabeth Miles, Aisha Miah, Kate Newbold, Mary Anne Tanay, F. Adab, Sarah Jefferies, Christopher Scrase, B. Yap, Roger A’Hern, Mark Sydenham, Marie A. Emson, Emma Hall - The Lancet Oncology 2011 被引用: 1,689

  20. Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression

    著者: Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, J. Guigay, A. Dimitrios Colevas, Lisa Licitra, Kevin J. Harrington, Stefan Kasper, Everett E. Vokes, Caroline Even, Francis P. Worden, Nabil F. Saba, Lara Carmen Iglesias Docampo, Robert I. Haddad, Tamara Rordorf, Naomi Kiyota, Makoto Tahara, Mark Lynch, Vijayvel Jayaprakash, Li Li, Maura L. Gillison - Oral Oncology 2018 被引用: 800

  21. Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma

    著者: Robert H.I. Andtbacka, Frances A. Collichio, Kevin J. Harrington, Mark R. Middleton, Gerald Downey, Katarina Öhrling, Howard L. Kaufman - Journal for ImmunoTherapy of Cancer 2019 被引用: 438

  22. Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma

    著者: Lisa Haas, Anais Elewaut, Camille L. Gérard, Christian Umkehrer, Lukas Leiendecker, Malin Pedersen, Izabela Kręcioch, David Hoffmann, Maria Novatchkova, Mario Kuttke, Tobias Neumann, Inês Pires da Silva, Harriet Witthock, Michel A. Cuendet, Sebastian Carotta, Kevin J. Harrington, Johannes Zuber, Richard A. Scolyer, Georgina V. Long, James S. Wilmott, Olivier Michielin, Sakari Vanharanta, Thomas Wiesner, Anna C. Obenauf - Nature Cancer 2021 被引用: 196

  23. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

    著者: Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra, Barbara Burtness, Makoto Tahara, Danny Rischin, Gustavo Vasconcelos Alves, Iane Pinto Figueiredo Lima, Brett Hughes, Y. Pointreau, Sercan Aksoy, Simon Laban, Richard Greil, Martin Burian, Marcin Hetnał, Jean‐Pierre Delord, Ricard Mesı́a, Miren Taberna, John Waldron, Christian Simon, Vincent Grégoire, Kevin J. Harrington, Ramona F. Swaby, Yayan Zhang, Burak Gümüşçü, Behzad Bidadi, Lillian L. Siu, Danny Rischin, Brett Hughes, Bo Gao, Margaret McGrath, Richard Greil, Dietmar Thurnher, Thorsten Fuereder, Martin Burian, Sylvie Rottey, Jean‐Pascal Machiels, Paul Clement, Stéphanie Henry, S. Deheneffe, Gustavo Vasconcelos Alves, Iane Pinto Figueiredo Lima, Josiane Mourão Dias, Pedro Rafael Martins De Marchi, Milena Perez Mak, Andrea Juliana Gomes, Dalvaro Oliveira de Castro Junior, Tatiane Cardoso Motta, Mônica Luciana Agostinho Padoan, Ana Paula Victorina, Sérgio Jobim Azevedo, Lillian L. Siu, Stephanie Yasmin Brule, John Hilton, Chang Shu Wang, Nathaniel Bouganim, Marc Webster, John Walker, Neil Chua, Ángela R. Zambrano, Alicia Quiroga Echeverri, Oscar Mauricio Niño Gomez, Carlos Alberto Ortiz, Luis Alejandro Rojas, Andrés Cardona Zorilla, Olga Marcela Urrego Meléndez, Petra Holečková, Bohuslav Melichar, Jakub Cvek, Jana Prausová, Milan Vošmik, Jean‐Pierre Delord, Xavier Zasadny, Lionnel Geoffrois, Yungan Tao, Y. Pointreau, Rainer Fietkau, Marlen Haderlein, Andreas Müller, Ursula C. Schroeder, Barbara Wollenberg, Simon Laban, Philipp Ivanyi, Viktor Gruenwald, Philippe Schafhausen, Orit Gutfeld, Iris Gluck, Aron Popovtzer, Amichay Meirovitz, Salem Billan, Baruch Brenner, Aron Popovtzer, Dror Limon, Lisa Licitra, Francesco Perri, Francesco Caponigro, Martina Violati, Daris Ferrari, Franco Nolè, Federica Bertolini ほか 90 名 - The Lancet Oncology 2024 被引用: 210

  24. Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651

    著者: Robert I. Haddad, Kevin J. Harrington, Makoto Tahara, Robert L. Ferris, Maura L. Gillison, Jérôme Fayette, Amaury Daste, P. Koralewski, Bogdan Żurawski, Miren Taberna, Nabil F. Saba, Milena Perez Mak, Andrzej Kawecki, Gustavo Girotto, Miguel Ángel Álvarez-Avitia, Caroline Even, Joaquin Gabriel Reinoso Toledo, Alexander Guminski, Urs Müller‐Richter, Naomi Kiyota, Mustimbo Roberts, Tariq Aziz Khan, Karen Miller-Moslin, Wei Li, Athanassios Argiris - Journal of Clinical Oncology 2022 被引用: 158